IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

DADHA PHARMA LLP

LLPIN : ABZ-7598|ROC: RoC-ChennaiActive
Last Updated On : 15-04-2024
LLPINABZ-7598
LLP NameDADHA PHARMA LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Chennai
Date of Incorporation09-01-2023
Registered AddressNew No. 187 Old No. 121, St. Marys Road, Alwarpet, Teynampet Chennai Chennai Tamil Nadu 600018
Email ID[email protected]
Total Obligation of Contribution98,70,800
Main division of business activity to be carried out in India21001
Description of main divisionManufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic
Date of last financial year end for Statement of Accounts and Solvency2023-03-31
Date of last financial year end for Annual Return filed31-03-2023
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
00087519MOHANCHAND PRADEEP DADHA09-01-2023
00104032SHUBDA DADHA09-01-2023
DADHA PHARMA LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Chennai, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 09-01-2023 and last updated on 15-04-2024. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, DADHA PHARMA LLP has a total contribution of INR 98,70,800. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is New No. 187 Old No. 121, St. Marys Road, Alwarpet, Teynampet Chennai Chennai Tamil Nadu 600018. Correspondence or inquiries may be sent to the official email address, [email protected].
For those interested in further details, below are some frequently asked questions: